Zobrazeno 1 - 10
of 257
pro vyhledávání: '"C Piscitelli"'
Autor:
Amy Paller, Adelaide A Hebert, John E Jett, Philip M Brown, David S Rubenstein, Stephen C Piscitelli
Publikováno v:
British Journal of Dermatology. 188
There is a need for efficacious non-steroidal topical therapies for atopic dermatitis (AD) without restrictions relating to duration, the extent of use and application sites. Tapinarof (VTAMA®; Dermavant Sciences, Inc., USA) is a first-in-class, non
Autor:
Bruce Strober, Linda Stein Gold, Robert Bissonnette, April W. Armstrong, Leon Kircik, Stephen K. Tyring, Stephen C. Piscitelli, Philip M. Brown, David S. Rubenstein, Anna M. Tallman, Mark G. Lebwohl
Publikováno v:
Journal of the American Academy of Dermatology. 87(4)
Tapinarof cream 1% once daily, an aryl hydrocarbon receptor-modulating agent, was significantly more efficacious than vehicle and well tolerated in two 12-week phase 3 trials in adults with mild to severe plaque psoriasis.To assess long-term safety,
Autor:
Mark G. Lebwohl, Linda Stein Gold, Bruce Strober, Kim A. Papp, April W. Armstrong, Jerry Bagel, Leon Kircik, Benjamin Ehst, H. Chih-ho Hong, Jennifer Soung, Jeff Fromowitz, Scott Guenthner, Stephen C. Piscitelli, David S. Rubenstein, Philip M. Brown, Anna M. Tallman, Robert Bissonnette
Publikováno v:
The New England journal of medicine. 385(24)
Tapinarof cream is a topical aryl hydrocarbon receptor-modulating agent under investigation for the treatment of psoriasis. Tapinarof modulates the expression of interleukin-17 and the skin-barrier proteins filaggrin and loricrin.We conducted two ide
Autor:
G. Maragliano, C. Piscitelli, C. Iorio, M. Cavaliere, G. Pinna, T. Carucci, M. Cao, M.C. De Nardo, A. Clemente, C. Guadagno, M. Di Feliciantonio, F. Barletta
Publikováno v:
Italian Journal of Gynaecology and Obstetrics. 35:115
Autor:
Linda Stein Gold, Mark Lebwohl, Robert Bissonnette, Bruce Strober, Anna M Tallman, Philip M Brown, Stephen C Piscitelli, David S Rubenstein
Publikováno v:
SKIN The Journal of Cutaneous Medicine. 6:s51
N/A
Autor:
James Del Rosso, Scott Guenthner, Chih-ho Hong, John E Jett, Philip M Brown, David S Rubenstein, Stephen C Piscitelli
Publikováno v:
SKIN The Journal of Cutaneous Medicine. 6:s50
N/A
Autor:
Michael McLaughlin, Lawrence Charles Parish, Stephen C. Piscitelli, Wayne DellaMaestra, John E. Jett, Tooraj Joseph Raoof, Janet DuBois, Mark S. Lee, Timothy Wilson, Matthew C. Somerville, Glenn Tabolt
Publikováno v:
American Journal of Clinical Dermatology
Background Tapinarof is a novel topical therapeutic aryl hydrocarbon receptor modulating agent in development for the treatment of psoriasis and atopic dermatitis. Objective This multicenter, open-label trial assessed the safety, tolerability, pharma
Autor:
John E. Jett, Jonathan I. Silverberg, David Rubenstein, Robert Bissonnette, Lawrence Eichenfeld, Anna M Tallman, Stephen C. Piscitelli
Publikováno v:
SKIN The Journal of Cutaneous Medicine. 5:s62
N/A
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Ivy Song, Stephen C. Piscitelli, Juhin Patel, Brian Wynne, Steve Weller, Julie Borland, Mike Choukour, Fred Jerva
Publikováno v:
European Journal of Clinical Pharmacology
Purpose Dolutegravir (DTG) is primarily metabolized by UGT1A1 with CYP3A as a minor route. Carbamazepine (CBZ) is a potent inducer of these enzymes; thus, the effect of oral extended-release CBZ on DTG pharmacokinetics (PK) was evaluated to provide d